Back

Relative effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against hospitalizations and mortality according to frailty score: a post-hoc analysis of the DANFLU-1 trial

31 August 2024 (12:00 - 12:40)
Organised by: Logo
Congress Presentation Part of: Cardiovascular outcome studies in the elderly Cardiovascular Disease in the Elderly ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Caroline Espersen

Herlev-Gentofte University Hospital, Gentofte (Denmark)

6 More presentations in this session

Presentation thumbnail
The long-term clinical benefit of early versus delayed invasive strategies in elderly patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention
Assistant Professor J. Choe (Pusan, KR)
Abstract Slides Video
Presentation thumbnail
Clinical prediction model of main adverse cardiovascular and cerebrovascular events for elderly patients with acute coronary syndrome
Doctor J. Xu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Clinical management and outcomes of patients with infective endocarditis according to frailty status
Doctor C. Perez Garcia (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Risk of death, thromboembolic events, and bleeding in elderly patients with Atrial Fibrillation and Clinical Complexity who are not taking oral anticoagulation.
Doctor T. Bucci (Perugia, IT)
Abstract Slides Video
Presentation thumbnail
Effect of high-dose vs. standard-dose quadrivalent influenza vaccine on death and hospitalizations in older adults with cardiovascular disease: a prespecified analysis of the DANFLU-1 study
Mr J. Christensen (Hellerup, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular outcome studies in the elderly

The Event

Event poster

ESC Congress 2024

31 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Effect of high-dose vs. standard-dose quadrivalent influenza vaccine on death and hospitalizations in older adults with cardiovascular disease: a prespecified analysis of the DANFLU-1 study
thumbnail
Congress Session
Late-Breaking Clinical Trials: vaccinations in cardiovascular prevention
thumbnail
Congress Presentation
DANFLU-2: High-Dose vs. Standard-Dose Influenza Vaccine and Cardio-Respiratory Outcomes in Older Adults

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources